Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.5B | 10.2B | 9.8B | 9.6B |
| Cost of revenue | 5.3B | 5.8B | 5.1B | 5.2B |
| Gross profit | 5.3B | 4.5B | 4.7B | 4.4B |
| Operating expense | ||||
| Research & development | 822.8M | 776.5M | 735.1M | 711.3M |
| Selling general and admin | 1.1B | 1.4B | 1.1B | 1.1B |
| Other operating expenses | — | — | — | — |
| Operating income | 3.3B | 2.3B | 2.9B | 2.6B |
| Non operating interest income | ||||
| Income | 50.9M | 54.1M | — | 79.0M |
| Expense | 184.2M | 192.6M | 206.5M | 168.0M |
| Other income expense | — | — | — | — |
| Pretax income | 3.2B | 2.1B | 2.7B | 2.5B |
| Tax provision | 323.4M | 265.7M | 339.4M | 366.6M |
| Net income | 2.9B | 1.9B | 2.4B | 2.1B |
| Basic EPS | 0.2 | 0.1 | 0.2 | 0.1 |
| Diluted EPS | 0.2 | 0.1 | 0.2 | 0.1 |
| Basic average shares | 14.9B | 14.9B | 14.9B | 15.0B |
| Diluted average shares | 15.3B | 15.3B | 15.3B | 15.4B |
| EBITDA | 7.3B | 6.6B | 6.7B | 6.5B |
| Net income from continuing op. | 2.9B | 1.9B | 2.4B | 2.1B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |